MADRIGAL PHARMACEUTICALS, INC. Annual Return On Equity in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Madrigal Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2016 to 2023.
  • Madrigal Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was -71.8 %, a 75.5% increase year-over-year.
  • Madrigal Pharmaceuticals, Inc. annual Return On Equity for 2023 was -219 %, a 18.8% increase from 2022.
  • Madrigal Pharmaceuticals, Inc. annual Return On Equity for 2022 was -270 %, a 169% decline from 2021.
  • Madrigal Pharmaceuticals, Inc. annual Return On Equity for 2021 was -101 %, a 56.4% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -219 +50.8 +18.8% Jan 1, 2023 Dec 31, 2023
2022 -270 -170 -169% Jan 1, 2022 Dec 31, 2022
2021 -101 -36.2 -56.4% Jan 1, 2021 Dec 31, 2021
2020 -64.3 -45.5 -241% Jan 1, 2020 Dec 31, 2020
2019 -18.8 -10.8 -133% Jan 1, 2019 Dec 31, 2019
2018 -8.09 +29.4 +78.4% Jan 1, 2018 Dec 31, 2018
2017 -37.5 +28.6 +43.3% Jan 1, 2017 Dec 31, 2017
2016 -66 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.